...
首页> 外文期刊>Journal of Polymers and the Environment >Guar Gum-Alginate Gel Coated Etherified Fenugreek Seed Mucilage-Alginate Microhybrids as Stomach-Targeting Flurbiprofen-Cargos
【24h】

Guar Gum-Alginate Gel Coated Etherified Fenugreek Seed Mucilage-Alginate Microhybrids as Stomach-Targeting Flurbiprofen-Cargos

机译:瓜尔胶 - 藻酸盐凝胶涂层醚化的春素格子粘液 - 藻酸盐微苞剂作为胃靶向的佛罗夫芬 - 尸体

获取原文
获取原文并翻译 | 示例
           

摘要

The present investigation aimed at developing core-shell structured partially etherified fenugreek seed mucilage (EFSM)-sodium alginate (SA) based microhybrids for controlled delivery of flurbiprofen (FLU) by combined gastroretentive bioadhesion and floating approaches. In this milieu, EFSM (degree of carboxymethyl substitution, 0.71) was firstly synthesized and analyzed through H-1 NMR and SEM studies. FLU-loaded EFSM-SA core hybrids were subsequently afforded by Ca2+-induced gelation protocol with and without incorporating low-density additives (such as, sunflower oil and calcium silicate) in the formulations. The core matrices were then coated by bioadhesive guar gum (GG)-SA gel membrane utilizing interfacial complexation technique. The developed microhybrids portrayed outstanding drug entrapping efficiency (DEE, 45-89%) and delayed drug eluting behaviour (Q(8h), 56-85%). These attributes were significantly influenced by various formulation variables like polymer-blend (EFSM:SA) ratios, low-density additive types and GG-SA coating inclusion. The drug dissolution profile of the core-shell structured microhybrids (F-7) obeyed zero-order kinetic model and its drug transport was driven by case-II mechanism. The formulation (F-7) also demonstrated excellent gastroretentive characteristics and biodegradability. The molar mass ((M) over bar (c)) between crosslinks of microhybrids (F-7) calculated utilizing Flory-Rehner equation was decreased with temperature. Furthermore, the microhybrids were characterized for drug-excipients compatibility, thermal behaviour, drug crystallinity and surface morphology. These novel composite matrices were thus evidenced to be appropriate for controlled intragastric delivery of FLU for inflammation and arthritis management.
机译:本发明的研究旨在开发核心壳结构的部分醚化的Fenugreek种子粘膜(EFSM)基于藻酸钠(SA)的微杂,用于通过组合的胃肠纤维生物粘附和浮动方法对照絮凝剂(流感)进行控制。在该Milieu中,首先合成并通过H-1 NMR和SEM研究分析EFSM(羧甲基取代度,0.71)。随后通过Ca2 +诱导的凝胶化方案提供流感的EFSM-SA核杂种,并且在制剂中不掺入低密度添加剂(例如,向日葵油和硅酸钙)。然后通过生物粘附的瓜尔胶(GG)-SA凝胶膜涂覆核基质,利用界面络合技术。发育的微杂草描绘出优异的药物诱捕效率(DEE,45-89%)和延迟药物洗脱行为(Q(8h),56-85%)。这些属性受到聚合物共混物(EFSM:SA)比,低密度添加剂类型和GG-SA涂层包衣等各种配方变量的显着影响。核心壳结构化微杂核(F-7)的药物溶出曲线遵守零级动力学模型及其药物运输是由案例-II机制驱动的。制剂(F-7)还表明了优异的胃肠引入特性和生物降解性。利用血液再葫芦方程计算的微苞(F-7)的交联之间的摩尔质量((m))与温度降低。此外,微杂于药物赋形剂的表征,热行为,药物结晶度和表面形态。因此,这些新型复合基质被证明是适合于对炎症和关节炎管理进行控制的胃内输送。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号